• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

DiaSorin

MedTech 100 roundup: Industry skies to all-time high

April 19, 2021 By Sean Whooley

The medtech industry hit a slight lull in the early stages of 2021 and, after signs of a rebound, it has soared beyond levels ever before seen. MassDevice‘s MedTech 100 Index had been building up steam in the month of April, rising from 102.16 points at the beginning of March all the way to 109.39 to […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Align Technology, Amgen, DiaSorin, Five Prime Therapeutics, Luminex, Medline Industries Inc., MedTech 100 Index, Microsoft, Nuance Communications Inc., Siemens Healthineers, Thermo Fisher Scientific, Varian Medical Systems, Vicarious Surgical

DiaSorin to buy Luminex for $1.8B

April 12, 2021 By Sean Whooley

DiaSorin announced that it agreed to acquire Luminex in an all-cash transaction worth approximately $1.8 billion. Saluggia, Italy-based DiaSorin’s purchase at $37 per share of Luminex represents a 23.1% premium to Luminex shareholders based on the unaffected closing stock price of the company on Feb. 24, 2021, which was the date prior to press rumors […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Mergers & Acquisitions Tagged With: DiaSorin, Luminex

MedTech 100 roundup: Ringing in the New Year with another high

January 4, 2021 By Sean Whooley

For the third time in the past four weeks, stocks within the medtech industry climbed to never-before-seen heights as 2021 reared its head. Previous highs have largely been a result of the FDA granting Moderna emergency use authorization for its vaccine candidate and its subsequent rollout to the U.S., joining the one made by Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX), […]

Filed Under: Business/Financial News, Featured, Funding Roundup, MassDevice Earnings Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Boston Scientific, Corinth MedTech, coronavirus, COVID-19, COVID-19 vaccine, Defense Production Act, DiaSorin, MedTech 100 Index, Medtronic, Olympus, Omnia Medical, Teleflex, U.S. Biomedical Advanced Research and Development Authority (BARDA), Veran Medical Technologies, Z-Medica

DiaSorin gains BARDA funding for COVID-19 testing kit

December 30, 2020 By Sean Whooley

DiaSorin Molecular announced that it received federal funding from BARDA for its Simplexa COVID-19 direct testing kit. Cypress, Calif.-based DiaSorin’s undisclosed funding total received from the Biomedical Advanced Research and Development Authority (BARDA) is slated to support the validation and submission of the test for FDA 510(k) clearance and the ramp-up of manufacturing capacity for […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Funding Roundup, Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: DiaSorin

What kinds of COVID-19 tests are out there?

July 10, 2020 By Nancy Crotti

Months into the pandemic, the FDA continues to grant emergency use approval (EUA) to new tests to detect the virus that causes COVID-19 and the antibodies that indicate a person has had it. To date, the FDA has granted EUAs for 171 tests —142 molecular tests, 27 antibody tests, and 2 antigen tests. Given the ever-changing […]

Filed Under: Diagnostics, Featured, Genomics/Molecular Diagnostics, Research & Development Tagged With: Abbott, coronavirus, COVID-19, DiaSorin, FDA, Mayo Clinic, Roche

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS